Research location
Sittard
Netherlands
Advertisement
Research activity in Sittard
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 53 trials and 53 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sittard
53 linked trials · page 1 of 2Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521 · 2025-08-26 · 1 site observation
RECRUITING
Prospective Data Collection Initiative on Thoracic MalignanciesNCT06996249 · 2025-08-15 · 1 site observation
RECRUITING
Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell LymphomaNCT06220032 · 2024-08-15 · 1 site observation
RECRUITING
REsponsible roLl-out of E-heAlth Through Systematic Evaluation - Heart Failure StudyNCT05654961 · 2022-01-01 · 1 site observation
UNKNOWN
A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab AdministrationNCT03689972 · 2018-11-27 · 1 site observation
COMPLETED
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung CancerNCT03540420 · 2018-07-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.NCT03228108 · 2018-04-03 · 1 site observation
COMPLETED
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast CancerNCT03425838 · 2017-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223NCT04995614 · 2017-04-01 · 1 site observation
COMPLETED
Management of Low-risk (Grade I and II) DCISNCT02492607 · 2017-02-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboNCT02284568 · 2015-01-12 · 1 site observation
COMPLETED
Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a MastectomyNCT02112682 · 2014-06-01 · 1 site observation
TERMINATED
Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic ShoesNCT02061059 · 2014-03-01 · 1 site observation
UNKNOWN
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With ExemestaneNCT02109913 · 2014-03-01 · 1 site observation
UNKNOWN
Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple SclerosisNCT01795872 · 2013-09-01 · 1 site observation
COMPLETED
Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast CancerNCT01898117 · 2013-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Trastuzumab & Pertuzumab Followed by T-DM1 in MBCNCT01835236 · 2013-03-03 · 1 site observation
COMPLETED
Systemic Therapy With or Without Upfront Surgery in Metastatic Breast CancerNCT01392586 · 2012-02-01 · 1 site observation
TERMINATED
Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.NCT01405872 · 2011-09-01 · 1 site observation
COMPLETED
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyNCT01381874 · 2011-08-24 · 1 site observation
COMPLETED
Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® TreatmentNCT01285401 · 2011-02-01 · 1 site observation
COMPLETED
Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER StudyNCT01239238 · 2010-11-01 · 1 site observation
COMPLETED
Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)NCT00910598 · 2009-09-01 · 1 site observation
UNKNOWN
Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)NCT00940719 · 2009-08-01 · 1 site observation
COMPLETED
Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's DiseaseNCT00748488 · 2008-09-01 · 1 site observation
COMPLETED
Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisNCT00662649 · 2008-02-01 · 1 site observation
COMPLETED
Various G-CSF Regimens to Prevent Infection During ChemotherapyNCT00536081 · 2008-01-01 · 1 site observation
COMPLETED
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)NCT00623103 · 2008-01-01 · 1 site observation
COMPLETED
Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson DiseaseNCT00558025 · 2007-10-01 · 1 site observation
COMPLETED
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoNCT00548405 · 2007-10-01 · 1 site observation
COMPLETED
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeNCT00505388 · 2007-07-01 · 1 site observation
COMPLETED
BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New DoseNCT00459667 · 2007-05-01 · 1 site observation
COMPLETED
A Study for Patients With Multiple SclerosisNCT00870155 · 2007-02-01 · 1 site observation
TERMINATED
Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple SclerosisNCT00420212 · 2007-01-01 · 1 site observation
COMPLETED
A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)NCT00441675 · 2007-01-01 · 1 site observation
COMPLETED
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate CancerNCT00312013 · 2006-05-01 · 1 site observation
COMPLETED
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast CancerNCT00333775 · 2006-03-01 · 1 site observation
COMPLETED
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive SymptomsNCT00297778 · 2006-03-01 · 1 site observation
COMPLETED
Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.NCT00314977 · 2006-02-01 · 1 site observation
COMPLETED
Treatment Of Symptomatic Asthma In ChildrenNCT00197106 · 2005-06-01 · 1 site observation
COMPLETED
A Study for Patients With Secondary Progressive Multiple SclerosisNCT00869726 · 2004-12-01 · 1 site observation
COMPLETED
A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart DiseaseNCT00134264 · 2004-07-01 · 1 site observation
TERMINATED
Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)NCT00086671 · 2004-04-01 · 1 site observation
COMPLETED
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsNCT00099502 · 2003-11-01 · 1 site observation
COMPLETED
Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor FluctuationsNCT00148512 · 2003-03-01 · 1 site observation
COMPLETED
BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up StudyNCT00185211 · 2002-08-01 · 1 site observation
COMPLETED
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)NCT00095238 · 2002-06-01 · 1 site observation
COMPLETED
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast CancerNCT00045032 · 2001-11-01 · 1 site observation
COMPLETED
PROACT - Pre-Operative Arimidex Compared To TamoxifenNCT00232661 · 2000-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.